Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
US12018057B2 · kind B2 · utility
0Cited by
44References
10Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jan 14, 2021 |
| Grant date | Jun 25, 2024 |
| Priority date | — |
| Expiry date | Jan 14, 2041 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides novel peptide inhibitors of the interleukin-23 receptor, and related compositions and methods of using these peptide inhibitors to treat or prevent a variety of diseases and disorders, including inflammatory bowel diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.